Glenmede Trust’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $919K | Buy |
10,160
+1,261
| +14% | +$116K | ﹤0.01% | 762 |
|
|
2025
Q4 | $800K | Buy |
+8,899
| New | +$844K | ﹤0.01% | 786 |
|
|
2025
Q1 | $1.46M | Sell |
12,896
-60,020
| -82% | -$6.42M | 0.01% | 609 |
|
|
2024
Q4 | $7.7M | Buy |
72,916
+28,362
| +64% | +$3.04M | 0.04% | 376 |
|
|
2024
Q3 | $4.81M | Buy |
44,554
+27,673
| +164% | +$3.02M | 0.02% | 447 |
|
|
2024
Q2 | $1.83M | Buy |
16,881
+3,990
| +31% | +$470K | 0.01% | 573 |
|
|
2024
Q1 | $1.7M | Sell |
12,891
-3,587
| -22% | -$448K | 0.01% | 604 |
|
|
2023
Q4 | $2.01M | Sell |
16,478
-2,960
| -15% | -$330K | 0.01% | 557 |
|
|
2023
Q3 | $2.18M | Sell |
19,438
-6,955
| -26% | -$883K | 0.01% | 505 |
|
|
2023
Q2 | $3.41M | Hold |
26,393
| – | – | 0.02% | 447 |
|
|
2023
Q1 | $3.41M | Sell |
26,393
-476
| -2% | -$59.8K | 0.02% | 447 |
|
|
2022
Q4 | $3.43M | Sell |
26,869
-287
| -1% | -$33.3K | 0.02% | 446 |
|
|
2022
Q3 | $2.84M | Sell |
27,156
-738
| -3% | -$81K | 0.02% | 456 |
|
|
2022
Q2 | $2.93M | Sell |
27,894
-412
| -1% | -$48.9K | 0.02% | 474 |
|
|
2022
Q1 | $3.62M | Sell |
28,306
-1,513
| -5% | -$182K | 0.02% | 464 |
|
|
2021
Q4 | $3.68M | Buy |
29,819
+1,162
| +4% | +$152K | 0.02% | 469 |
|
|
2021
Q3 | $4.07M | Sell |
28,657
-96
| -0.3% | -$14.1K | 0.02% | 437 |
|
|
2021
Q2 | $4.49M | Sell |
28,753
-848
| -3% | -$137K | 0.02% | 411 |
|
|
2021
Q1 | $4.6M | Sell |
29,601
-2,408
| -8% | -$373K | 0.02% | 405 |
|
|
2020
Q4 | $4.79M | Buy |
32,009
+4,231
| +15% | +$598K | 0.03% | 405 |
|
|
2020
Q3 | $3.67M | Sell |
27,778
-409
| -1% | -$53.4K | 0.02% | 418 |
|
|
2020
Q2 | $3.27M | Sell |
28,187
-1,198
| -4% | -$138K | 0.02% | 426 |
|
|
2020
Q1 | $4.27M | Hold |
29,385
| – | – | 0.02% | 478 |
|
|
2019
Q4 | $4.27M | Buy |
29,385
+926
| +3% | +$128K | 0.02% | 478 |
|
|
2019
Q3 | $3.79K | Sell |
28,459
-1,422
| -5% | -$184K | 0.02% | 505 |
|
|
2019
Q2 | $3.42K | Buy |
29,881
+50
| +0.2% | +$5.86K | 0.02% | 542 |
|
|
2019
Q1 | $3.7K | Sell |
29,831
-20,151
| -40% | -$2.29M | 0.02% | 528 |
|
|
2018
Q4 | $5.03K | Buy |
49,982
+17,547
| +54% | +$1.97M | 0.02% | 448 |
|
|
2018
Q3 | $4.14M | Sell |
32,435
-276
| -0.8% | -$32.8K | 0.02% | 523 |
|
|
2018
Q2 | $3.54M | Buy |
32,711
+1,963
| +6% | +$214K | 0.02% | 521 |
|
|
2018
Q1 | $3.6M | Hold |
30,748
| – | – | 0.02% | 548 |
|
|
2017
Q4 | $3.6M | Sell |
30,748
-17,620
| -36% | -$1.99M | 0.02% | 548 |
|
|
2017
Q3 | $5.5M | Sell |
48,368
-2,821
| -6% | -$326K | 0.02% | 463 |
|
|
2017
Q2 | $6.06M | Hold |
51,189
| – | – | 0.03% | 451 |
|
|
2017
Q1 | $6.06M | Buy |
51,189
+5,123
| +11% | +$581K | 0.03% | 451 |
|
|
2016
Q4 | $4.61M | Sell |
46,066
-1,420
| -3% | -$152K | 0.03% | 483 |
|
|
2016
Q3 | $5.99M | Sell |
47,486
-448
| -0.9% | -$55.4K | 0.03% | 443 |
|
|
2016
Q2 | $5.6M | Buy |
47,934
+5,311
| +12% | +$601K | 0.03% | 439 |
|
|
2016
Q1 | $4.41M | Sell |
42,623
-326
| -0.8% | -$31.5K | 0.03% | 453 |
|
|
2015
Q4 | $4.28M | Buy |
42,949
+16,658
| +63% | +$1.63M | 0.03% | 459 |
|
|
2015
Q3 | $2.4M | Sell |
26,291
-14
| -0.1% | -$1.4K | 0.02% | 558 |
|
|
2015
Q2 | $2.79M | Sell |
26,305
-2,600
| -9% | -$288K | 0.02% | 502 |
|
|
2015
Q1 | $3.3M | Buy |
28,905
+106
| +0.4% | +$12.1K | 0.02% | 492 |
|
|
2014
Q4 | $3.17M | Sell |
28,799
-15
| -0.1% | -$1.58K | 0.02% | 479 |
|
|
2014
Q3 | $2.81M | Sell |
28,814
-39,720
| -58% | -$3.91M | 0.02% | 484 |
|
|
2014
Q2 | $6.91M | Buy |
68,534
+15,636
| +30% | +$1.53M | 0.06% | 365 |
|
|
2014
Q1 | $4.86M | Sell |
52,898
-9,124
| -15% | -$841K | 0.05% | 406 |
|
|
2013
Q4 | $5.61M | Buy |
62,022
+334
| +0.5% | +$28.9K | 0.06% | 372 |
|
|
2013
Q3 | $4.92M | Buy |
61,688
+5,838
| +10% | +$460K | 0.06% | 358 |
|
|
2013
Q2 | $4.06M | Buy |
+55,850
| New | +$4.18M | 0.05% | 377 |
|
Other funds holding ZBH
VCM
VPM
Glenmede Trust's ZBH Position: Q1 2026 in Review
Glenmede Trust increased its Zimmer Biomet (ZBH) stake by 14% in Q1 2026, buying an estimated $116K and bringing the position to 10,160 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #762.
Glenmede Trust first reported a position in ZBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $7.7M in Q4 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Glenmede Trust held 10,160 shares of Zimmer Biomet worth $919K as of Q1 2026.
- Glenmede Trust bought 1,261 Zimmer Biomet shares in Q1 2026, an estimated $116K.
- Zimmer Biomet made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #762 holding.
- Glenmede Trust first reported a position in Zimmer Biomet in Q2 2013 and has held it in 50 quarters since.
- Glenmede Trust's Zimmer Biomet position peaked at $7.7M in Q4 2024.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.